Ignite Creation Date:
2024-05-05 @ 9:42 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001295
Status:
COMPLETED
Last Update Posted:
2019-12-17
First Post:
1999-11-03
Brief Title:
Continuing Care and Treatment for Patients With CancerAIDSSkin Disease
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Continuing Treatment for Children and Adults in the Center for Cancer Research
Status:
COMPLETED
Status Verified Date:
2016-08-23
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This protocol is to provide continuing medicalsurgicalradio-therapeutic care treatment and follow-up for NCI patients not currently entered on an active research protocol No investigational treatments will be administered on this protocol
Detailed Description:
Background
It may be in the interest of the CCR to continue to follow and treat certain subjects after they have completed their treatment and participation on a research protocol
Objective
To provide continuing treatment and medical follow-up for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on or eligible for another active research protocol
Eligibility
Subjects who have been previously enrolled on and received treatment according to an approved CCR research protocol clinical trial
It is in the best interest of the subject and the CCR for the subject to continue to receive standard care and follow-up at the NIH
Design
Medicalsurgicalradiotherapeutic care treatment and follow-up is provided for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on an active research protocol
No investigational treatments will be administered This protocol is not be used as a platform to perform pilot studies of off-label uses for standard agents
It may be in the interest of the CCR to continue to follow and treat certain subjects after they have completed their treatment and participation on a research protocol
Objective
To provide continuing treatment and medical follow-up for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on or eligible for another active research protocol
Eligibility
Subjects who have been previously enrolled on and received treatment according to an approved CCR research protocol clinical trial
It is in the best interest of the subject and the CCR for the subject to continue to receive standard care and follow-up at the NIH
Design
Medicalsurgicalradiotherapeutic care treatment and follow-up is provided for CCR subjects who have completed their treatment and participation on a research protocol and who are not currently entered on an active research protocol
No investigational treatments will be administered This protocol is not be used as a platform to perform pilot studies of off-label uses for standard agents
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 92-C-0094 | None | None | None |